Evidence map›Paper›PMID 21289622›Full record

ReviewClinical pharmacology and therapeutics2011

Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy.

W Sadee, D Wang, A C Papp, J K Pinsonneault, R M Smith, R A Moyer, A D Johnson

Abstract readReview
In one paragraph

Review in Clinical pharmacology and therapeutics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Identification of aFrontiers in pharmacology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Cytochrome P450 Enzymes and Drug Metabolism in Humans.International journal of molecular sciences · 2021
    Review
  9. Racial Disparity in Drug Disposition in the Digestive Tract.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

W SadeeProgram in Pharmacogenomics, Department of Pharmacology, The Ohio State University College of Medicine, Columbus, Ohio, USA. Wolfgang.Sadee@osumc.edu
D Wang
A C Papp
J K Pinsonneault
R M Smith
R A Moyer
A D Johnson

Funding

Expression Genetics in Drug TherapyU01GM092655 · NIGMS · OHIO STATE UNIVERSITY · PI SADEE, WOLFGANG · 2010 to 2014
$8.6M
Genetic and Epigenetic Regulation of Addiction GenesR01DA022199 · NIDA · OHIO STATE UNIVERSITY · PI SADEE, WOLFGANG · 2006 to 2010
$1.7M
NIDA NIH HHS DA022199NIDA NIH HHS R01 DA022199NIGMS NIH HHS GM092655NIGMS NIH HHS U01 GM092655
6 · The paper itself

Abstract

The use of pharmacogenomic biomarkers can enhance treatment outcomes. Regulatory polymorphisms are promising biomarkers that have proven difficult to uncover. They come in two flavors: those that affect transcription (regulatory single-nucleotide polymorphisms (rSNPs)) and those that affect RNA functions such as splicing, turnover, and translation (termed structural RNA SNPs (srSNPs)). This review focuses on the role of srSNPs in drug metabolism, transport, and response. An understanding of the nature and diversity of srSNPs and rSNPs enables clinical scientists to evaluate genetic biomarkers.

Indexed as

PharmacogeneticsPolymorphism, Single NucleotideBiomarkersGenetic MarkersGenetic VariationHumansPharmaceutical PreparationsRNABiomarkersGenetic MarkersPharmaceutical PreparationsRNA

Identifiers

PMID21289622
PMCPMC3251919

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.